drugset / Trial / NCT00407251

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

NCT00407251

Phase 2 Completed 73 enrolled British Columbia Cancer Agency
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy of patupilone chemotherapy and to find out what effects (good and bad) the drug Patupilone has on patients with prostate cancer that has progressed following hormone treatment and docetaxel chemotherapy.

Timeline

Start
2007-02
Primary completion
2010-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Patupilone Small molecule